1. Home
  2. Industries
  3. Finance & Banking
  4. Venture Capital
  5. Synaptogenix

Synaptogenix

3 Decision Makers · 3 Verified Contacts

synaptogen.com
📍 New York, NYFinance & Banking🗓 Est. 2012👥 Under 10 employees
See 3 verified contactsCheck synaptogen.com emails

About Synaptogenix

Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

Email Deliverability

↻ Sign in to regenerate

DNS health check for synaptogen.com

Loading…

Leadership & Decision Makers

Contact details of 3 Synaptogenix decision makers

Robert Weinstein

Chief Financial Officer
No contact data available

Daniel Alkon

President & Chief Scientific Officer
No contact data available

Alan Tuchman

Chief Executive Officer
No contact data available

General Emails

General company emails, e.g. customer support lines

admin@synaptogen.com Admin Team
ir@synaptogen.com Investor Relations
nir@synaptogen.com Investor Relations

Verify Synaptogenix Emails

Similar Companies like Synaptogenix

Blackstone Innovations Investments

blackstone.com
Finance & Banking · New York, NY · Est. 1985 · Under 10 employees · $500M–$1B Why similar: shared segment: Finance & Banking, Venture Capital · same size band · same country

HQ: New York, NY

Citi Venture Capital International

citi.com
Finance & Banking · New York, NY · Est. 2001 · 11–50 employees Why similar: shared segment: Finance & Banking, Venture Capital · same country

HQ: New York, NY

PJT Partners

pjtpartners.com
Finance & Banking · New York, NY · Est. 2015 · 501–1000 employees Why similar: shared segment: Finance & Banking, Venture Capital · same country

HQ: New York, NY

Jefferies

jefferies.com
Finance & Banking · New York, NY · Est. 1962 · 1001–5000 employees Why similar: shared segment: Finance & Banking, Venture Capital · same country

HQ: New York, NY

Explore similar firms in the Finance & Banking sector
Company Info
synaptogen.com
New York, NY
Legal Name Synaptogenix, Inc.
Employees 1-10
Founded Date 2012
Company Type For Profit
Stock Symbol OTCQX:SNPX
Operating Status Active
Last Funding Type Post-IPO Equity
Phone Number 973-242-0005
Last Investment Activity Apr 24, 2024
Investments Activity Apr 24, 2024Apr 4, 2024Apr 3, 2024
Where this data comes from

Records are compiled from publicly available sources and checked as described in our methodology.

See full email addresses & phone numbers Create a free account — no credit card needed, beta access open.
Get Free Access Sign in

Frequently Asked Questions about Synaptogenix

What does Synaptogenix do?

Synaptogenix is a clinical-stage biopharmaceutical company that develops novel therapies for neurodegenerative diseases.

Where is Synaptogenix headquartered?

Synaptogenix is headquartered in New York, NY.

When was Synaptogenix founded?

Synaptogenix was founded in 2012.

How many employees does Synaptogenix have?

Synaptogenix has approximately 1-10 employees.

What industry is Synaptogenix in?

Synaptogenix operates in the Finance & Banking industry.

How do I contact Synaptogenix?

You can contact Synaptogenix via email at admin@synaptogen.com or ir@synaptogen.com, headquartered in New York, NY.

Explore more
Finance & Banking companies Companies in New York, NY Email format guide: Finance & Banking All industries Check synaptogen.com emails Request removal of a contact